Sandage Bobby W Phd

Avg. Two Year Performance

(62%) Avg. Purchase Return
(27%) Compound
25% Avg. Sale Return
12% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return15%20%(< 1%)58%(62%)
Purchase Success Rate2 of 22 of 21 of 22 of 20 of 2
Average Sale Return11%12%37%59%25%
Sale Success Rate2 of 22 of 22 of 22 of 22 of 2

Coronado Biosciences, Inc.

Drugs » Biotechnology

President, Director:

Holdings: 22.31K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Indevus Pharmaceuticals Inc.

Drugs » Biotechnology

Executive Vice President:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Oxigene Inc.

Drugs » Biotechnology

Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--